Mohammad Abu Sayem (Mohammad A Sayem)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Dendritic Cells

Vascular Endothelial Growth Factor

Top Venues

Blood cancer journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Yang, Salar Abbas, Mohammad Abu Sayem, Avik Dutta, Golam Mohi
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm. Blood cancer journal 13 (1) (2023)
Mohammed Ferdous-Ur Rahman, Yue Yang, Bao T Le, Avik Dutta, Julia Posyniak, Patrick Faughnan, Mohammad Abu Sayem, Nadine S Aguilera, Golam Mohi
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm. Nature communications 13 (1) (2022)
Tomonari Kinoshita, Mohammad Abu Sayem, Tomonori Yaguchi, Budiman Kharma, Kenji Morii, Daiki Kato, Shigeki Ohta, Yukihiko Mashima, Hisao Asamura, Yutaka Kawakami
Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors. Cancer science 112 (4) (2021)